GlassScriptPhysician profile
Michele M Tacl
NPI 1598269003
$1,201.40
in general payments reported to CMS, 2019-2025
17 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $193 · 2023: $117 · 2024: $507 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $306.81 | 2021-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $172.79 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.70 | 2024 | Ofev |
| Genzyme Corporation | $134.64 | 2024 | |
| Electromed, INC. | $75.90 | 2024-2025 | Smartvest |
| Zoll Respicardia, INC. | $72.54 | 2024 | Remede System |
| Merck Sharp & Dohme LLC | $60.62 | 2025 | Zerbaxa |
| Ani Pharmaceuticals, INC. | $34.88 | 2024 | Purified Cortrophin Gel |
| Pulmonx Corporation | $29.32 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Harmony Biosciences LLC | $28.15 | 2023 | Wakix |
| United Therapeutics Corporation | $27.15 | 2024 | Tyvaso |
| Vifor Pharma, INC. | $24.98 | 2024 | Zemaira |
| Regeneron Healthcare Solutions, INC. | $23.24 | 2025 | Dupixent |
| Shionogi INC | $20.85 | 2025 | Fetroja |
| Janssen Pharmaceuticals, INC | $17.66 | 2023 | Xarelto |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $15.23 | 2023 | Yupelri |
| Mallinckrodt Hospital Products INC. | $12.94 | 2023 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Tacl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.